Statistics

Total Visits

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants33

Select a period of time:

Number of views in the range

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants18

Views

Views
May 20243
June 20241
July 20244
August 20244
September 20242
October 20242
November 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
United Kingdom1
 

Top cities views

Views
Chicago2
Fort Worth1